Search results
1 lip 2009 · A generic version of Multaq has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Multaq and have been approved by the FDA: dronedarone hydrochloride tablet;oral. Manufacturer: LUPIN.
Compare Flecainide vs Multaq head-to-head with other drugs for uses, ratings, cost, side effects and interactions.
5 dni temu · The generic ingredient in MULTAQ is dronedarone hydrochloride. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dronedarone hydrochloride profile page. DrugPatentWatch ® Litigation and Generic Entry Outlook for Multaq.
1 lut 2024 · Lupin, a leading pharmaceutical company, has achieved a significant milestone with the USFDA approval of its Abbreviated New Drug Application (ANDA) by the United States Food and Drug Administration (USFDA).
Compare Multaq vs Propafenone head-to-head with other drugs for uses, ratings, cost, side effects and interactions.
Dronedarone, sold under the brand name Multaq, is a class III antiarrhythmic medication developed by Sanofi-Aventis. [citation needed] It was approved by the US Food and Drug Administration (FDA) in July 2009.
Multaq is indicated for the maintenance of sinus rhythm after successful cardioversion in adult clinically stable patients with paroxysmal or persistent atrial fibrillation (AF). Due to its safety profile, Multaq should only be prescribed after alternative treatment options have been considered.
